Rapid At-Home COVID-19 Antigen Tests Have Reportedly Provided 44% Accuracy
The latest COVID-19 variant, Pirola, has raised awareness among scientists due to its increased number of mutations. This new variant is suspected to be stronger and more contagious than previous strains. The concern arises as many Rapid At-Home COVID-19 tests have been reported to be ineffective in diagnosing positive COVID-19 samples due to viral load variance. PCR testing remains the most accurate form of testing for COVID-19, and combined with the iSWAB-RC-EL transport media, results can be achieved in less time.
The iSWAB-RC-EL is FDA Cleared for infectious disease detection of SARS-CoV-2 (from nasal and saliva samples) using legally marketed molecular diagnostic assays.
Key Advantages:
-Suitable for use without a nucleic acid extraction step.
-Samples are stable for several weeks at ambient temperature
-Non-hazardous, alcohol-free, and guanidine-free
-Efficient viral inactivation
Mawi DNA Technologies’ mission is to be a global leader in biological sample collection with the main objective of simplifying genomics and proteomics workflows.
For a Free Consultation with our Experts and more information on our products,
Mawi DNA Technologies Partners with GenoBank.io To Tokenize Our Groundbreaking…...
October 14, 2024 – We are thrilled to announce that Mawi DNA Technologies has officially partnered with READ MORE
Mawi DNA Partners with Tempus AI and Tally Health™ to…...
October 7, 2024 – Customers frequently ask what swabs are compatible with our iSWAB® non-invasive sample collection technology. Although most swab types can be used with our system, incl...
READ MORESolena Ag and Mawi DNA Partner to Revolutionize Soil Health…...
January 4, 2024 – Solena Ag, a leader in soil health insights for sustainable agriculture, and Mawi DNA Technologies (Mawi DNA), a pioneer in high-integrity sample collection and storage, today anno...
READ MORE
